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Abstract
OBJECTIVE: To investigate the clinical effects of
modified Dachengqi Tang (DCQT) on promoting
gastrointestinal motility in post-operative esopha-
geal cancer patients.
METHODS: Sixty postoperative esophageal cancer
patients were enrolled and randomly assigned to
the modified treatment group or the control group
(30 patients in each group). Patients in the treat-
ment group were given DCQT made from decocted
herbs and administered via nasojejunal tube at a
dosage of 150 mL. Gastrointestinal motility was as-
sessed by recording time for recovery of bowel
sounds, flatus, defecation, and the total amount of
gastric drainage during the first three postopera-
tive days. Plasma motilin (MTL) and vasoactive in-
testinal peptide (VIP) were measured one hour be-
fore and three days after surgery.
RESULTS: Compared with the control group, the
times to first bowel sound, flatus, and defecation
were significantly shorter and there was less gastric
drainage in the treatment group (P < 0.01, P < 0.01,
P < 0.01, and P < 0.05, respectively). In the treat-
ment group, postoperative plasma MTL was signifi-
cantly higher (P < 0.01) and VIP was significantly
lower than those in the control group (P < 0.05).
There was no difference found in either MTL or VIP
from before to after operation in the treatment
group (P > 0.05). MTL was significantly lower and
VIP was higher postoperatively in the control
group, compared to before surgery (P < 0.01).
CONCLUSION: Modified DCQT effectively im-
proved decreased gastrointestinal motility in post-
operative esophageal cancer patients by increasing
MTL and reducing VIP.
© 2015 JTCM. All rights reserved.
Key words: Dachengqi Tang; Esophageal neo-
plasms; Gastrointestinal motility; Nasojejunal infu-
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INTRODUCTION
Esophageal cancer is a common malignancy, and the
morbidity is increasing yearly. Each year about 200 000
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people die from esophageal cancer, which makes it the
eighth leading cause of morbidity and sixth leading
cause of mortality worldwide.1 Early surgery is the
main treatment for esophageal cancer. However, it
tends to induce temporary gastrointestinal dysfunction
which is characterized by abdominal distension, belly-
ache, nausea, vomiting, weak bowel sounds, and de-
layed defecation. In some cases, acute gastroparalysis
and paralytic ileus may occur, which might result in
death. Lee et al 2 reported that 50% of esophagectomy
patients showed significantly delayed gastric emptying
in the early stage after surgery. These disorders prolong
recovery, increase discomfort, and increase hospitaliza-
tion costs because of additional recovery days.3 There-
fore, promoting gastrointestinal motility after surgery
in affected patients is important to decreasing compli-
cations and improving prognosis. The etiology of post-
operative gastrointestinal dysfunction is unclear and at-
tributed to multiple mechanisms. The mechanisms may
include inhibitory sympathetic input,4 injury or discon-
nection of the vagus nerve,5 release of hormones6 or neu-
rotransmitters,4 effects of anesthesia or analgesics,7,8 neg-
ative pressure in the thoracic cavity, psychological stress
like anxiety and tension,9-11 or inflammatory reactions.12
Various methods have been used to promote gastroin-
testinal motility in the clinical setting without much
success. The current management for gastrointestinal
motility recovery after esophageal cancer surgery uses
Western Medicine, includes: routine postoperative in-
dwelling stomach tube; continuous gastrointestinal de-
compression; fasting; postoperative nutritional sup-
port; gastric lavage with a warm saltwater solution;
and, use of prokinetic agents. However, the treatments
are often expensive and have frequent complications.
Therefore, mild and economical Traditional Chinese
Medicine (TCM) that can promote the recovery of gas-
trointestinal function are being increasingly studied.
Dachengqi Tang (DCQT), first documented in the
classical TCM pharmacopoeia Treatise on Fevers,13 is
an herbal prescription composed of four component
herbs or minerals: Dahuang (Radix Et Rhizoma Rhei
Palmati), Mangxiao (Nalrii Sulfas), Houpu (Cortex
Magnoliae Officinalis), and Zhishi (Fructus Aurantii Im-
maturus). DCQT has been used to treat gastrointesti-
nal disorders for more than a thousand years. This
study aimed to investigate the clinical effects and the
mechanisms of nasojejunal infused DCQT on gastro-
intestinal motility in post-operative esophageal cancer
patients.
MATERIALS ANDMETHODS
Patients
Patients were recruited from the Thoracic Surgery De-
partment of Shandong Provincial Tumor Hospital. Pa-
tients who met all the following criteria were recruited
in this study: age range from 18 to 75 years old; con-
firmed diagnosis and resection of esophageal cancer ac-
cording to NCCN guidelines;14 enteral nutrition being
given via a nasal feeding tube after surgery; and compli-
ance to treatment. Those who met one of the following
criteria were excluded: an existing intestinal anastomo-
sis after surgery; allergies; poor compliance, indicated
by taking less than 80% or more than 120% of the pre-
scribed medication; or receiving medicine or other
treatment promoting gastrointestinal function. Sixty
patients from March to July 2010 were selected and
consecutively numbered according to their admission
time. Patients were randomly divided into a treatment
and control group with 30 patients in each according
to a random number table. In the treatment group,
there were 23 males and 7 females with a mean age of
(60 ± 3) years (range 49 to 67 years). In the treatment
group, 9 patients underwent intrathoracic anastomosis
and 21 underwent cervical anastomosis. In the control
group, there were 24 males and 6 females with a mean
age of (60 ± 7) years (range 42 to 77 years). The con-
trol group had 6 patients that underwent intrathoracic
anastomosis and 24 that underwent cervical anastomo-
sis. There were no significant differences between the
treatment and control groups in sex, age, or surgical ap-
proach. This clinical study was approved by the Medi-
cal Ethics and Human Clinical Trial Committee, and
was conducted in accordance with the guidelines of the
Declaration of Helsinki. All participants were clearly in-
formed and consented.
Preparation of modified DCQT
A single dosage of modified DCQT consisted of Da-
huang (Radix Et Rhizoma Rhei Palmati) 10 g, Mangx-
iao (Nalrii Sulfas) 5 g, Houpu (Cortex Magnoliae Offici-
nalis) 15 g, Zhishi (Fructus Aurantii Immaturus) 15 g,
Danggui (Radix Angelicae Sinensis) 15 g, Huangqi (Ra-
dix Astragali Mongolici) 15 g, Chishao (Radix Paeoniae
Rubra) 15 g, and Wuyao (Radix Linderae Aggregatae)
10 g. The air-dried herbs were purchased from the
Pharmacy Department of the Affiliated Hospital of
Shandong University of Traditional Chinese Medicine
(Shandong, China). All herbs except Mangxiao (Nalrii
Sulfas) were soaked in 500 mL cold water for 1 h. The
rhubarb was soaked separately. Herbs were decocted
with gentle heat for 15 min. Then, rhubarb and 200 mL
cold water were added and filtered to yield the decoc-
tion. Finally, the Mangxiao (Nalrii Sulfas) was dis-
solved in the decoction and the solution was concen-
trated. The final yield of the prepared decoction was
150 mL, which was stored in a sterile package at 4℃.
Treatments
All patients received esophageal cancer resection and
esophagus-stomach anastomosis (intrathoracic anasto-
mosis or cervical anastomosis). After surgery, all pa-
tients were given routine therapies, including fasting,
gastrointestinal decompression, antibiotics, and enteral
nutrition. Each patient in the treatment group was giv-
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en a daily single dose of 150 mL DCQT on the morn-
ing of the first, second, and third day after the first en-
teral nutrition was provided 24 h after surgery. The de-
coction was infused through a nasojejunal feeding tube
at 37 ℃ with the infusing thermostat at a speed of
80-100 drops per minute. The same regimen was fol-
lowed in the controls, except that modified DCQT
was replaced by 150 mL normal saline. No other medi-
cation affecting gastrointestinal motility was given to ei-
ther group. During the infusion, all patients were close-
ly observed for any adverse effects such as diarrhea, bel-
lyache, or abdominal distention.
Experimental methods
The time to restoration of flatus, defecation, and intes-
tinal sounds after surgery were recorded. The intestinal
sound restoration was defined as at least three clear
bowel sounds per minute calculated by a three-min-
ute-long auscultation every 2 h. The total amount of
gastric drainage in the 3 days after surgery was mea-
sured. The plasma concentrations of motilin (MTL)
and vasoactive intestinal peptide (VIP) were measured
by taking fasting venous blood samples 1 h before and
3 days after surgery (on the morning of the fourth day)
separately with test tubes containing 40 µL of trasylol
and 30 µL Na2-ethylene diamine tetraacetic acid
(EDTA). The samples were centrifuged immediately at
3000 rpm (1500 ×g) and 4 ℃ for 10 min and the sepa-
rated serum was stored at﹣80 ℃ for subsequent anal-
ysis. Before measurement, the cryopreserved plasma
was thawed at room temperature and centrifuged at
3000 rpm and 4 ℃ for 5 min for radioimmunoassay
with an intelligence γ-radioimmunoassay measuring in-
strument. The radioimmunoassay kit was supplied by
the Beijing Puerweiye Biotechnology Company (Bei-
jing, China). The SN-695B intelligence γ-radioimmu-
noassay apparatus was produced in the First Ring In-
strument Factory affiliated to Shanghai Institute of Nu-
clear Research (Shanghai, China).
Statistical analysis
SPSS 13.0 (SPSS Inc., Chicago, IL, USA) was used
for data analysis. Data were expressed as mean ± stan-
dard deviation (xˉ ± s). T-tests were conducted for
differences between groups. P < 0.05 was considered
significant.
RESULTS
The restoration of flatus, defecation, and intestinal
sounds in the treatment group occurred much more
quickly than those in the control group (P < 0.01, Ta-
ble 1). There was significantly less total drainage in the
treatment group than that in the control group (P <
0.05, Table 1). Among all the participants, only one
woman in the treatment group had diarrhea on the
end of the fourth day, which recovered quickly after
discontinuing therapy.
There was no significant difference in preoperative plas-
ma MTL or VIP concentrations between the treatment
and control groups (both P > 0.05 ). The postoperative
MTL was significantly higher and postoperative VIP
was significantly lower in the treatment group com-
pared with the control group (P < 0.01, P < 0.05). No
significant differences in MTL or VIP were found
from before to after surgery within the treatment
group (both P > 0.05). However, the postoperative
MTL was significantly lower and VIP was significantly
higher than preoperative values in the control group
(both P < 0.05) (Table 2).
DISCUSSION
According to TCM theory, decreased gastrointestinal
motility in postoperative esophageal cancer patients re-
sults from Qi and blood stagnation and disordered
Zang and Fu organs (i.e. lung, spleen, kidney, heart,
stomach, small intestine, and large intestine). There-
fore, TCM treatment aims to remove stasis to promote
the flow of Qi and activate blood circulation, restore
the Zang and Fu organs, and purge and dispel toxins
and excess heat. DCQT is mainly composed of Da-
huang (Radix Et Rhizoma Rhei Palmati), Mangxiao
(Nalrii Sulfas), Houpu (Cortex Magnoliae Officinalis),
and Zhishi (Fructus Aurantii Immaturus). The decoc-
tion aims to unblock interior Qi and purge heat to im-
prove bowel movement. The Dahuang (Radix Et Rhi-
zoma Rhei Palmati)15-17 and Mangxiao (Nalrii Sulfas)18
dispel excess internal heat and toxins, soften hard mass-
es, and purge and cleanse the gastrointestinal tract.
However, postoperative esophageal cancer patients
tend to be weak and deficient in both Qi and blood, so
catharsis should be mild. Therefore, we lowered the ca-
Indicator
Time to first flatus (h)
Time to first defecation (h)
Time to bowel sounds restoration (h)
Total gastric drainage (mL)
Treatment group (n=30)
58±8
97±10
34±6
643±187
Control group (n=30)
65±6
113±12
43±7
777±229
Table 1 Postoperative clinical indicators among the two groups ( xˉ ± s)
Notes: control group was treated with routine therapies (fasting, gastrointestinal decompression, antibiotics, and enteral nutrition); treat-
ment group was given a daily single dose of 150 mL modified Dachengqi Tang on the morning of the first, second, and third day after the
first enteral nutrition was provided 24 h after surgery.
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thartic drugs Dahuang (Radix Et Rhizoma Rhei Palma-
ti) from12 to 10 g and Mangxiao (Nalrii Sulfas) from 9
to 5 g. DCQT also includes Houpu (Cortex Magnoliae
Officinalis) to promote Qi circulation, eliminate damp-
ness, and relieve dyspepsia. Zhishi (Fructus Aurantii Im-
maturus) eliminates phlegm and stasis,19 and Danggui
(Angelica sinensis) nourishes and activates blood, re-
lieves pain, and lubricates and tonifies the intestine.
Huangqi (Radix Astragali Mongolici) is added to DC-
QT for Qi tonification and Yang lifting.20 Chishao (Ra-
dix Paeoniae Rubra) is added to clear heat, cool blood,
and eliminate stasis to alleviate pain.21 Finally, Wuyao
(Radix Linderae Aggregatae) is used to promote Qi cir-
culation and relieve pain.22,23 In addition to the pharma-
cological effect of the herbs, the monosaccharides, poly-
saccharides, and electrolytes contained in the decoction
also provide nutrients for the gastrointestinal mucosa.
Overall, DCQT unblocks interior Qi and nourishes
the Zang and Fu organs, particularly for those who
have just underwent major surgery.
We found that DCQT dramatically improved patient
postoperative condition as demonstrated by clinical
symptoms and laboratory indexes. Flatus, defecation,
and intestinal sounds were restored much more quickly
in the treatment group than in the control group.
Meanwhile, there was significantly less gastric drainage
in the treatment group compared with the control
group. Therefore, modified DCQT improved gastroin-
testinal motility after surgery, which is consistent with
other studies.24-27 Among all treatment patients, only
one woman had diarrhea on the fourth day, which re-
covered soon after discontinuing DCQT treatment.
This suggests that DCQT treatment is relatively safe,
but the specific dosage for individuals should be fur-
ther investigated.
Gastrointestinal motility is modulated by several hor-
mones. MTL, a polypeptide hormone containing 22
amino acids, is secreted by endocrine M cells and acts
at motilin receptors to promote gastrointestinal motili-
ty by stimulating migrating myoelectric complex phaseⅢ and pepsin production.28-30 Studies have shown that
motilin receptor agonists ameliorated functional dys-
pepsia by increasing the level of plasma motilin.31,32 Lu
et al 33 found that plasma MTL levels in preoperative
esophageal cancer patients were higher compared with
normal people, and MTL levels increased gradually
with the development of cancer. In this study, no differ-
ences in MTL levels were found between esophageal
cancer patients and healthy patients. This may be be-
cause patients had earlier stage esophageal cancer, or
the small sample size was too small. Experimental re-
sults indicate that the postoperative level of plasma
MTL was significantly higher in the treatment group
than that in the control group, but there was no signifi-
cant difference between the two groups preoperatively.
The postoperative level of MTL was significantly lower
than the preoperative level in the control group but
not the treatment group. These MTL results indicate
that gastrointestinal motility recovered earlier in the
treatment group.
VIP, a 28-amino acid polypeptide acting at G-pro-
tein-coupled receptors in the gastrointestinal tract,34 in-
duces intestinal smooth muscle relaxation, stimulates
water and bicarbonate secretion, and inhibits secretion
of gastric acid and pepsin.35 One animal study found
that VIP has an inhibitory effect on gastrointestinal
motility and gastric emptying.29 In this study, VIP was
significantly lower in the treatment group compared
with the control group postoperatively while there was
no significant difference between the two groups preop-
eratively. The level of plasma VIP was significantly
higher after surgery in the control group but not the
treatment group. Therefore, postoperative gastrointesti-
nal motility was suppressed in the control group, but
not the treatment group. DCQT promoted gastrointes-
tinal motility after esophageal cancer resection by im-
proving MTL and reducing VIP, which is in accor-
dance with previous study.36
Studies have shown that there are various approaches
for DCQT administration, including oral administra-
tion, enema, or nasal feeding.27,37-41 We found that nasal
feeding via nasojejunal tube may be superior because of
higher tolerance, lower risk of reflux, and faster absorp-
tion.
DCQT significantly promoted gastrointestinal motility
in postoperative esophageal cancer patients by improv-
Plasma concentration
Preoperative MTL
Postoperative MTL
Preoperative VIP
Postoperative VIP
Treatment group (n=30)
334±70a
322±78b,e
159±29c
175±34d,f
Control group (n=30)
387±85
230±60g
163±26
200±43h
Table 2 Pre- and post-operative plasma MTL and VIP (ng/L, xˉ ± s)
Notes: control group was treated with routine therapies (fasting, gastrointestinal decompression, antibiotics, and enteral nutrition); treat-
ment group was given a daily single dose of 150 mL modified Dachengqi Tang on the morning of the first, second, and third day after the
first enteral nutrition was provided 24 h after surgery. MTL: motilin; VIP: vasoactive intestinal peptide. Independent-sample t-test: aP >
0.05, vs the preoperative control group, bP < 0.01, vs the postoperative control group. Independent-sample t-test: cP > 0.05 vs the preopera-
tive control group. Paired-sample t-test: dP < 0.05 vs the postoperative control group. Paired-sample t-test: eP > 0.05 vs the preoperative
treatment group, gP < 0.01 vs the preoperative control group. Paired-sample t-test: fP > 0.05 vs the preoperative treatment group, hP < 0.01
vs the preoperative control group.
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ing MTL and reducing VIP. However, the sample size
was small. More research at the molecular level should
be performed to study the mechanism, determine ap-
propriate DCQT dosages, and evaluate the safety of
this decoction.
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